These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 21322979

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The effect of thio-TEPA on developing and established mammalian bladder tumors.
    Murphy WM, Soloway MS.
    Cancer; 1980 Mar 01; 45(5):870-5. PubMed ID: 6790154
    [Abstract] [Full Text] [Related]

  • 24. [Preliminary results of a randomized study between intravesical adriamycin and thio-tepa in the treatment of superficial tumors of bladder].
    Allona Moncada A, Santos García Vaquero I, Polo Villar G, Díaz González R, González Martín M, Zuloaga Gómez A, Martínez Torres JL, Rodríguez Alvarez J, Duarte Vázquez JJ, Megino López JF.
    Arch Esp Urol; 1984 Mar 01; 37(2):113-22. PubMed ID: 6431914
    [No Abstract] [Full Text] [Related]

  • 25. [Depression of bone marrow after intravesical use of Thio-tepa].
    Malling N.
    Ugeskr Laeger; 1980 Sep 29; 142(40):2630-1. PubMed ID: 6777928
    [No Abstract] [Full Text] [Related]

  • 26. Long-term pharmacokinetics of thio-TEPA, TEPA and total alkylating activity following i.v. bolus administration of thio-TEPA in ovarian cancer patients.
    Hagen B, Neverdal G, Walstad RA, Nilsen OG.
    Cancer Chemother Pharmacol; 1990 Sep 29; 25(4):257-62. PubMed ID: 1688514
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Severe bone marrow damage after instillation of thio tepa into the bladder].
    Edgren B, Forsgren L, Boström H.
    Nord Med; 1966 Apr 28; 75(17):481. PubMed ID: 4956156
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Transmurally absorbed intravesical chemotherapy with dimethylsulfoxide in an animal model.
    Yaman O, Ozdiler E, Sözen S, Göğüş O.
    Int J Urol; 1999 Feb 28; 6(2):87-92. PubMed ID: 10226813
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Thio-Tepa in the chemotherapy and chemical prevention of papillary neoplasms of the bladder].
    Delzotto L, Viggiano G, Marchini M, Barbui PE.
    Minerva Med; 1977 Jun 02; 68(28):1957-60. PubMed ID: 406584
    [No Abstract] [Full Text] [Related]

  • 35. [Spontaneously cured pancytopenia due to intravesical thio-tepa, apropos of one case].
    Archimbaud JP, Calcat P, Martel JP.
    J Urol Nephrol (Paris); 1973 Dec 02; 79(12 Pt 2):487-8. PubMed ID: 4216648
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Morphologic effects of thio-TEPA on mammalian urothelium. Changes in abnormal cells.
    Murphy WM, Soloway MS, Lin CJ.
    Acta Cytol; 1978 Dec 02; 22(6):550-4. PubMed ID: 104512
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Own experiences with the treatment of papillomatous bladder neoplasms by intracystic administration of Thio-Tepa].
    Dobrzecki W, Kaczmarek A.
    Pol Przegl Chir; 1977 Jun 02; 49(6a):743-8. PubMed ID: 407554
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.